Complementary and Alternative Medicine for
Urological Symptoms: Saw Palmetto (Serenoa
repens) for Benign Prostatic Hyperplasia
(CAMUS)
Principal Investigator: E. David Crawford, MD
COMIRB Protocol Number: 07-0183
NIDDK/NIH Number: U01 DK063833
***********************************************************
*********************************
Purpose of This Research
To determine whether Saw Palmetto (Serenoa
repens) reduces unpleasant urinary symptoms caused
by a type of enlarged prostate known as benign
prostatic hyperplasia or BPH. These urinary
symptoms can include a slow, interrupted or weak
urinary stream, urgency, leaking, or more frequent
urination, especially at night.
Who Can Take Part
To be eligible for this study, you must:
· be at least 45 years of age,
· not have had surgery for your enlarged prostate,
· not have another cause for your urinary
symptoms
(such as prostate or bladder cancer, urinary tract
disease, or neurological problems)
· have a prostate specific antigen (PSA) level
below
10 ng/ml, and
· be able to complete the study in the opinion of
the
investigator.
Cost to Patient
Qualified participants will receive Saw Palmetto or
placebo (a pill that looks like medicine, but will have
no medical effect on you) at no cost. All clinic visits,
procedures, and lab tests will be covered by the grant
except for two physician visits (the initial visit and a
visit at 72 weeks). Both of these visits are considered
routine care for treating men with enlarged prostates
and will, therefore, be billed to you or your insurance
company.
Length of Study Involvement
Your involvement in this study will be
approximately 1.5
years.
For further information please call:
Cliff Jones -or- Patricia DeVore
Section of Urologic Oncology University of Colorado
Denver
Telephone: 720-848-1387
Fax: 720-848-1390
E-Mail: cliff.jones@ucdenver.edu -or-
patricia.devore@ucdenver.edu